SEC Form 4 research
| Issuer | Akers Biosciences, Inc. |
|---|---|
| Tickers | AKER, MYMD, QCLS, TNFA |
| Reporting owners | 32 |
| Officers and directors | 5 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-10-01 | Silverman Joshua | A | 77,390 | $0 | Not reported |
| 2026-10-02 | 2026-07-10 | Silverman Joshua | A | 16,620 | $0 | Not reported |
| 2026-10-02 | 2026-04-13 | Silverman Joshua | A | 16,806 | $0 | Not reported |
| 2026-10-02 | 2026-04-13 | Silverman Joshua | A | 100,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.